Results 261 to 270 of about 322,217 (303)

A 3D Human Bone and Bone Marrow‐on‐a‐Chip Model for In Vitro Bone Remodeling and Immune Cell Maintenance

Advanced Science, EarlyView.
This study presents a human Bone (and Bone Marrow)‐on‐a‐Chip model based on native human bone scaffolds and autologous cells. Dynamic perfusion and sequential cell seeding replicate the physiological bone remodeling process in vitro, enabling the long‐term culture of functional, mature bone marrow immune subpopulations.
Nina Stelzer, Melanie‐Jasmin Ort, Kristian Händler, Emely Bortel, Ioanna Maria Dimitriou, Martin Textor, Georg N. Duda, Janosch Schoon, Uwe Marx, Uwe Kornak, Annika Winter, Bernhard Hesse, Stefanie Donner, Sebastian Hardt, Oliver Klein, Simon Reinke, Malte Spielmann, Sven Geißler   +17 more
wiley   +1 more source

Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer. [PDF]

BMC Cancer
Feng Q, Ni C, Zhou F, Zhu J, Sun X, Qin Y, Xiang N, Wu D.   +7 more
europepmc   +1 more source

Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports. [PDF]

Discov Oncol
Huang Y, Zhang H, Fan D, Wang Z, Qin X, Sun X, Zhu L.   +6 more
europepmc   +1 more source

Breast cancer stem cells and circulating tumor cells: Dual drivers of progression and relapse. [PDF]

World J Stem Cells
Azizi Z, Er Urganci B, Acikbas I.
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow-up of high-grade serous ovarian cancer. [PDF]

Mol Oncol
Salmon C, Neves RPL, Stoecklein NH, Liffers ST, Siveke J, Kuhlmann JD, Wimberger P, Buderath P, Kimmig R, Kasimir-Bauer S.   +9 more
europepmc   +1 more source

Effect of preoperative biliary drainage on peripheral circulating tumor cells after pancreaticoduodenectomy in patients with resectable periampullary carcinoma and obstructive jaundice. [PDF]

Transl Gastroenterol Hepatol
Lin H, Deng B, Xin C, Li P, Wang T, Yu X, Jian Y, Wang D.   +7 more
europepmc   +1 more source

Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.

Blood
Fokkema C, Bertamini L, de Jong MME, Tahri S, Hofste Op Bruinink D, Kellermayer Z, Papazian N, den Hollander C, Vermeulen MPW, Stoetman ECG, van Beek G, Hoogenboezem R, van der Velden VHJ, Hulin C, Perrot A, Moreau P, Rowe M, Vieyra D, Carson R, van Duin M, Sanders MA, Broijl A, Sonneveld P, Cupedo T.   +23 more
europepmc   +1 more source

Diagnostic and Prognostic Utility of Cell-Surface Vimentin Positive Circulating Tumor Cells in Breast Cancer Using an Automated Negative Selection Platform. [PDF]

Diseases
Yeh MH, Lin MC, Tsai HJ, Liu YC, Wang TM, Hung WS, Lin CP, Liang CH, Tseng CJ.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Circulating Tumor Cells

Materials and Methods, 2017
In most solid tumors, it is distant metastases rather than the primary tumor which limit the prognosis. Distant metastases are caused by circulating tumor cells (CTCs) which actively invade the blood stream, attach to the endothelium in the target organ, invade the surrounding parenchyma, and form new tumors.
Sebastián A, García, Jürgen, Weitz, Sebastian, Schölch   +2 more
openaire   +3 more sources

Circulating Tumor Cells and Circulating Tumor DNA

Annual Review of Medicine, 2012
Solid tumors derived from epithelial tissues (carcinomas) are responsible for 90% of all new cancers in Europe, and the main four tumor entities are breast, prostate, lung, and colon cancer. Present tumor staging is mainly based on local tumor extension, metastatic lymph node involvement, and evidence of overt distant metastasis obtained by imaging ...
Catherine, Alix-Panabières, Heidi, Schwarzenbach, Klaus, Pantel   +2 more
openaire   +2 more sources